Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management

被引:17
作者
Lebin, Jacob A.
LeSaint, Kathy T.
机构
[1] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA
[2] San Francisco Div, Calif Poison Control Syst, San Francisco, CA USA
关键词
DIAZEPAM;
D O I
10.5811/westjem.2020.5.47810
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
As of April 21, 2020, more than 2.5 million cases of coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, have been reported in 210 countries and territories, with the death toll at 171,810. Both chloroquine and hydroxychloroquine have gained considerable media attention as possible therapies, resulting in a significant surge in demand. In overdose, both medications can cause severe, potentially life-threatening effects. Here, we present a brief overview of the pharmacology of chloroquine and hydroxychloroquine, manifestations of toxicity, and treatment considerations.
引用
收藏
页码:760 / 763
页数:4
相关论文
共 22 条
[1]   Paradoxical brain embolism shadowing massive pulmonary embolism [J].
Bagate, Francois ;
Bedet, Alexandre ;
Dessap, Armand Mekontso ;
Carteaux, Guillaume .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (08) :1527.e1-1527.e2
[2]  
Barry J, 2011, ANTIMALARIALS
[3]   INTENTIONAL CHLOROQUINE OVERDOSAGE [J].
BRITTON, WJ ;
KEVAU, IH .
MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 (09) :407-410
[4]  
California State Board of Pharmacy California Department of Consumer Affairs and Medical Board of California, STAT REG IMPR PRESCR
[5]   HYPOKALEMIA RELATED TO ACUTE CHLOROQUINE INGESTION [J].
CLEMESSY, JL ;
FAVIER, C ;
BORRON, SW ;
HANTSON, PE ;
VICAUT, E ;
BAUD, FJ .
LANCET, 1995, 346 (8979) :877-880
[6]   Treatment of acute chloroquine poisoning: A 5-year experience [J].
Clemessy, JL ;
Taboulet, P ;
Hoffman, JR ;
Hantson, P ;
Barriot, P ;
Bismuth, C ;
Baud, FJ .
CRITICAL CARE MEDICINE, 1996, 24 (07) :1189-1195
[7]   Therapeutic trial of diazepam versus placebo in acute chloroquine intoxications of moderate gravity [J].
Clemessy, JL ;
Angel, G ;
Borron, SW ;
Ndiaye, M ;
LeBrun, F ;
Julien, H ;
Galliot, M ;
Vicaut, E ;
Baud, FJ .
INTENSIVE CARE MEDICINE, 1996, 22 (12) :1400-1405
[8]  
Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI [10.1016/j.ijantimicag.2020.105949, 10.1016/j.ijantimicag.2020.106063]
[9]   CLINICAL-FEATURES AND MANAGEMENT OF POISONING DUE TO ANTIMALARIAL-DRUGS [J].
JAEGER, A ;
SAUDER, P ;
KOPFERSCHMITT, J ;
FLESCH, F .
MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1987, 2 (04) :242-273
[10]  
Johns Hopkins University of Medicine, COR RES CTR